Celanese (CE) just posted Q1 2026 results with revenue of US$2.3 billion and basic EPS of US$0.41, while trailing twelve month figures show revenue of US$9.5 billion and a basic EPS loss of US$9.85. Over recent quarters, revenue has ranged between US$2.2 billion and US$2.5 billion, with basic EPS swinging from a loss of US$17.55 in Q4 2024 to a profit of US$1.86 in Q2 2025 and a loss of US$12.39 in Q3 2025. This underscores how volatile margins have been for shareholders tracking the story. With analysts expecting a return to profitability over the coming years, this latest print keeps the focus firmly on whether earnings quality and margin stability can catch up with that recovery narrative.

See our full analysis for Celanese.

With the latest quarter on the books, the next step is to set these results against the most common market narratives around Celanese and see which views are supported by the numbers and which are challenged.

Losses Still Heavy On A 12 Month View

• Across the last twelve months, Celanese reported a basic EPS loss of US$9.85 and a net loss of US$1.1b on US$9.5b of revenue, even though Q1 2026 itself showed a small profit of US$45 million.
• Bears argue that multi year earnings declines and a trailing net loss of US$1.1b point to a business that is still under pressure. However, the swing from a US$1.9b loss in Q4 2024 to positive net income in Q1 2026 shows that results can move sharply in individual quarters, which could limit how confidently a bearish view can be based only on the latest run rate.
  • Critics highlight that losses have grown at about 49.7% per year over five years, and the trailing twelve month EPS loss of US$9.85 reflects that long stretch of weak profitability.
  • At the same time, quarterly net income excluding extra items has ranged from a loss of US$1.4b in Q3 2025 to a profit of US$204 million in Q2 2025 and US$45 million in Q1 2026, which shows how volatile the earnings base is that bears are extrapolating from.

Skeptics focus on the US$1.1b loss and weak interest coverage, while bulls point to recent profitable quarters as a sign the earnings power might be better than the trailing average suggests, so it is worth seeing how the full bearish case stacks up against swings like Q2 2025 and Q1 2026. 🐻 Celanese Bear Case

Valuation Signals Versus Weak Profitability

• The stock trades on a P/S of 0.7x versus 1.1x for the wider US chemicals industry and 2.1x for peers, and the current share price of US$62.12 sits well below the cited DCF fair value of about US$128.48.
• Bullish investors argue that this discount, combined with forecasts for earnings to turn positive and grow at about 64.77% per year, heavily supports a recovery story. Yet the trailing twelve month net loss of US$1.1b and weak interest coverage in the data serve as a clear check on how quickly that bullish thesis might show up in reported numbers.
  • Supporters of the optimistic view point out that analysts in the dataset expect Celanese to move from a US$1.1b loss to hundreds of millions of earnings over a few years, which would make a 0.7x P/S and a price around US$62.12 look low relative to both the industry and the DCF fair value of US$128.48 if those forecasts are met.
  • What stands out against that bullish narrative is that interest payments are currently not well covered by earnings on a trailing basis, so the company has to improve cash generation from a loss making starting point before the low P/S and the gap to DCF fair value can be fully justified by the accounts.

Revenue Holding Near US$9.5b, But Growth Is Modest

• Over the last year Celanese generated about US$9.5b of revenue, with quarterly sales moving between US$2.2b and US$2.5b, and the longer term revenue growth cited is 3.1% per year compared with an 11.3% per year figure for the broader US market.
• The consensus narrative suggests the company has meaningful earnings power tied to demand for engineered polymers and acetyls. However, the modest 3.1% annual revenue growth and unprofitable trailing twelve month position mean that any thesis about stronger future margins is starting from a base where volumes and pricing have not been growing as quickly as the wider market.
  • Consensus commentary talks about cost actions and portfolio moves helping margins when volumes recover, but the data here only show revenue hovering around US$9.5b to US$10.3b over recent twelve month windows, not a strong upswing in the top line so far.
  • Given that analysts in the dataset expect profit margins to move from a loss making level today to positive mid single digit levels over a few years, the current combination of modest 3.1% revenue growth and a US$1.1b trailing loss highlights how much of that margin story still lies ahead rather than in historical figures.

Bulls point to low P/S and margin improvement potential, while these revenue trends and trailing losses remind you to check how much of the upbeat story is already in the numbers and how much is still just in forecasts before leaning too heavily on the optimistic case. 🐂 Celanese Bull Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Celanese on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With both risks and potential rewards on the table, do not wait for the crowd to decide for you. Instead, weigh the trade offs and check the 3 key rewards and 1 important warning sign

See What Else Is Out There

Celanese is still working through a US$1.1b trailing loss, weak interest coverage, and only modest 3.1% annual revenue growth compared with the broader market.

If that level of earnings volatility and balance sheet pressure feels uncomfortable, you can quickly shift your focus toward companies screened for stronger financial footing through the solid balance sheet and fundamentals stocks screener (45 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.